Nitori Holdings (OTC:NCLTY) Stock, Quote.Headers.trade-ideas

Nitori Holdings Co Ltd is a Japanese holding company engaged in the sale of furniture and interior goods. It primarily operates home furnishing and fashion stores, along with other ventures such as the Nitori Mall and Corporate Enterprise, which focuses on corporate customers. It conducts these operations and more through its subsidiaries. The firm's products include bedding, curtains, cookware, tableware, tables, desks, and sofas. Nitori's operations are divided among manufacturing, trading company and logistics (which deals with imports and distribution centers), sales, and advertisement and publicity. Aside from its presence across Japan, the company operates in California, China, Huizhou, Indonesia, Shanghai, and Vietnam.

NITORI HOLDINGS CO U/ADR by Nitori Holdings Co., Ltd.

Nitori Holdings Co Ltd

Alta Global Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMA#NYSE">MMA</a>) ("Alta" or the "Company"), a pioneering technology company uniting passion and participation in global combat sports with a vision of converting 640 million fans to participants, is thrilled to announce a partnership with Conor McGregor, the iconic UFC champion and global superstar. This new deal envisions McGregor eventually becoming a significant stakeholder in the company, further solidifying Alta's influence in the MMA community.
"Conor McGregor's involvement is a game changer for Alta Global Group. His legacy and influence in the world of MMA and combat sports are unmatched. We are honored and thrilled to have his endorsement and support, which will be instrumental in revolutionizing the martial arts and combat sports landscape," Nick Langton, Founder and CEO of Alta, remarked.
McGregor, known for his unparalleled reach and influence, will leverage his extensive 63+ million fan base to promote Alta's innovative platform and products. As a former UFC Featherweight and Lightweight World Champion, the first to hold titles in two weight classes simultaneously, and a former Cage Warriors Featherweight and Lightweight Champion, McGregor's achievements have cemented his status as the biggest pay-per-view draw in MMA history. His fights have consistently broken records, with his bout at UFC 229 drawing 2.4 million buys and his boxing debut against Floyd Mayweather Jr. garnering over 5.3 million buys. McGregor's contribution to popularizing MMA and the UFC on a global scale is undeniable, and in 2021, Forbes recognized him as the world's highest-paid athlete, earning $180 million.
In a previous post to his social followers, McGregor expressed enthusiasm for Alta Global Group "My coach, John Kavanagh, is one of the founders of this amazing organization." "It's an amazing company doing amazing things in the martial arts space." "It's also supporting MMA gyms worldwide."
McGregor's role will be pivotal in promoting and growing Alta's current business offerings which serve all key stakeholders in the martial arts and combat sports community, consisting of fans, participants, coaches, gym owners and athletes. These include the following.
TrainAlta (<a href="https://pr.report/2dyx">www.trainalta.com</a>) partners with gyms and coaches to deliver a range of consumer products that drive participation in martial arts for fans and beginners, from access to basic online content through to immersive in-gym training experiences focused on various MMA techniques and related disciplines. Alta's in-gym training programs have historically generated an average of over $1,000 in gross revenue per member.
Hype (<a href="https://pr.report/2dyy">www.hype.co)</a> is a subscription-based mobile marketing platform designed to help gym owners, coaches and athlete partners grow revenue in today's age of social media. Priced at up to $299 per month with a recurring subscription model, also offers Alta an additional revenue stream by collecting up to 5% on all transactions processed through the platform.
MixedMartialArts.com (<a href="https://pr.report/2dyz">www.mixedmartialarts.com</a>) is a leading platform for the MMA community, providing access to MMA news and media, fighter data, fight schedules and access to the legendary Underground forum. The platform generates significant organic search traffic and has over 260,000 forum accounts, 350,000 monthly sessions and over 5 million followers across Facebook&#x2A;

News

Alta Global Partners with UFC Star Conor McGregor to Boost Combat Sports Participation

The Cuddle Collab collection launches&nbsp;Sept. 21&nbsp;and features over 180 items &mdash; from matching accessories to modern home d&eacute;cor, starting at just&nbsp;$3&nbsp;&mdash; inspired by beloved pet influencers

Target Unveils The Cuddle Collab, Its First Exclusive Collection For Pets And Pet Lovers; Collection Launches Sept. 21 And Features Over 180 Items Starting At $3

<a href="https://hirschsecure.com/">Hirsch</a>, a global security technology leader advancing physical security, video intelligence, cybersecurity, and digital identification solutions, announces the relaunch of its iconic brand and strengthened focus on the industry's most complete high-security, end-to-end platform. This milestone follows the <a href="https://www.identiv.com/iot/resources/press-releases/identiv-announces-security-business-asset-sale-transaction-receives-cfius-clearance">purchase of Identiv's physical and cybersecurity business units by Vitaprotech</a>, positioning Hirsch as the global leader in physical security, video intelligence, and identity solutions, protecting everything from small enterprises to critical national infrastructure.

INVE

Hirsch Relaunches Brand with Focus on End-to-End Security Solutions After Vitaprotech Acquisition

Wedbush analyst Jay McCanless upgrades LGI Homes (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGIH#NASDAQ">LGIH</a>) from Underperform to Neutral and raises the price target from $97 to $125.

Upgrades

Price Target

Analyst Ratings

LGIH

Wedbush Upgrades LGI Homes to Neutral, Raises Price Target to $125

Biotech

Health Care

General

RDHL

RedHill Biopharma Announced The Placement Of Low-dose Rifabutin-triple Therapy, Talicia, As An Empirically-prescribed First-line Option For Helicobacter Pylori Infection In The Newly Published American College Of Gastroenterology Clinical Guideline

PGI, a Western Canadian focused gas processing entity jointly owned by Pembina and KKR, has entered into agreements with Veren Inc. and certain affiliates thereof that include the acquisition of Veren&#39;s Gold Creek and Karr area oil batteries and support for future infrastructure development. The net purchase price related to the acquisition of the batteries is C$400 million&nbsp;(C$240 million, net to Pembina).
<div>PGI will acquire four batteries in the Gold Creek and Karr areas, which include natural gas handling capacity of 320 million cubic feet per day and liquids handling capacity of 53,000 barrels per day.</div>
<div>&nbsp;</div>
<div>Natural gas from the batteries is processed at PGI&#39;s Patterson Creek Gas Plant and both the batteries and the Patterson Creek Gas Plant are connected to Pembina&#39;s Peace Pipeline system.</div>
&nbsp;

Pembina Pipeline Reveals Pembina Gas Infrastructure's Agreement to Acquire Midstream Assets From Veren; Net Purchase Price Related To Acquisition Of Batteries Is C$400M

RNAC

The FDA Has Granted Rare Pediatric Disease Designation To Cartesian Therapeutics' Descartes-08 For Juvenile Dermatomyositis

In a recent development, Chinese President Xi Jinping has expressed his intent to strengthen ties with North Korea, despite indications of strained relations.
What Happened: Xi, on Monday, conveyed his desire to enhance cooperation and strategic communication with North Korea, the South China Morning Post <a href="https://www.scmp.com/news/china/diplomacy/article/3277740/xi-overlooks-differences-stress-china-north-korea-ties-anniversary-message?module=top_story&amp;pgtype=homepage">reported</a>. Xi&#8217;s message to North Korean leader Kim Jong Un, marking the 76th anniversary of North Korea&#8217;s founding, lauded the Workers&#8217; Party of Korea for its role in uniting North Koreans and fostering the country&#8217;s growth.
As per Xinhua, China&#8217;s state news agency, Xi underscored the 75th anniversary of diplomatic relations between China and the Democratic People's Republic of North Korea (DPRK), asserting that the bonds have &#8220;become stronger over time.&#8221;
Xi reiterated China&#8217;s commitment to maintain and develop &#8220;traditional friendly and cooperative relations&#8221; with North Korea, and to contribute towards fostering peace, stability, development, and prosperity in the region and globally.
See Also: <a href="https://www.benzinga.com/news/24/09/40678993/russias-president-flies-into-international-criminal-court-member-mongolia-defies-global-arrest-warra?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Russia&#8217;s President Flies Into International Criminal Court Member Mongolia, Defies Global Arrest Warrant</a>
Notably, the most recent known interaction between the two leaders was in January during the exchange of New Year's greetings. Post this, North Korea has been ramping up its diplomatic and military efforts with Russia, including a visit from Russian President Vladimir Putin in June &#8211; his first to Pyongyang in 24 years.
Two weeks post Putin's visit, North Korea switched its state television broadcasts from a Chinese satellite to a Russian one, hinting at a potential shift in alliances.
However, Xi&#8217;s recent message signifies China&#8217;s intent to continue strengthening its relationship with North Korea.
Why It Matters: The recent developments come in the backdrop of high-level security talks between <a href="https://www.benzinga.com/news/24/06/39358342/amid-russian-presidents-visit-to-kim-jong-uns-north-korea-china-resumes-high-level-security-talks-wi">China and South Korea</a> coinciding with Putin&#8217;s visit to North Korea in June. This was Putin&#8217;s first visit to North Korea since 2000.
Furthermore, North Korea&#8217;s switch from a <a href="https://www.benzinga.com/news/24/07/39689352/kim-jong-uns-north-korea-switches-to-russian-satellite-from-china-for-tv-broadcasts-experts-say-it-s">Chinese to a Russian satellite</a> for its state television broadcasts in July has sparked discussions about China's diminishing influence over Pyongyang.
Did You Know?
<ul>
<li>Congress Is Making Huge Investments.&nbsp;<a href="https://www.benzinga.com/gov-trades" target="_blank" rel="noreferrer noopener">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
Images by Foreign, Commonwealth &amp; Development Office via Flickr and The Presidential Press and Information Office via Wikimedia Commons
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

Global

Xi Jinping Vows To Strengthen China-North Korea Ties In Message To Kim Jong Un Amid Signs Of Diplomatic Strains

<ul>
<li>New data show improved tolerability in immunocompromised animals and no evidence of spreading to blood or tissues even at high doses</li>
<li>Tonix's synthetic horsepox vaccine platform has been selected by NIH's Project NextGen for clinical testing</li>
</ul>

TNXP

Tonix Pharmaceuticals Presented Data On Its Potential Mpox Vaccine TNX-801 In "Using Synthetic Biology To Battle Mpox" Talk At Immunology Symposium At The University Of Alberta, TNX-801 Vaccination Demonstrated Efficacy In Protecting Animals From Lethal Challenge With Clade I Mpox

Keybanc analyst Todd Thomas maintains Extra Space Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXR#NYSE">EXR</a>) with a Overweight and raises the price target from $172 to $178.

Keybanc Maintains Overweight on Extra Space Storage, Raises Price Target to $178

Methanex Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEOH#NASDAQ">MEOH</a>) disclosed that it has entered into a definitive agreement to acquire OCI Global&#8216;s international methanol <a target="_blank" href="https://www.benzinga.com/pressreleases/24/09/g40765411/methanex-corporation-signs-definitive-agreement-to-acquire-oci-globals-international-methanol-busi" rel="noreferrer noopener">business for $2.05 billion</a>.
The deal encompasses OCI&#8217;s stakes in two major methanol facilities in Beaumont, Texas, one of which also produces ammonia, along with a low-carbon methanol production and marketing business and an idled methanol facility in the Netherlands.
Rich Sumner, President and Chief Executive Officer of Methanex, said, &#8220;This is a unique opportunity to create value by acquiring two highly attractive North American methanol assets that will further strengthen our global production base and we expect it will be immediately accretive to free cash flow per share.&#8221;
&#8220;The Beaumont plants benefit from access to North America&#8217;s abundant and favourably-priced supply of natural gas feedstock, and are expected to increase our <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">global methanol production by over 20 percent</a>.&#8221;
Through the OCI acquisition, Methanex expects to gain $30 million in annual cost synergies from reduced logistics and administrative expenses.
With minimal integration costs due to similar operating models, Methanex plans to enhance value by applying its global expertise and incorporating OCI assets into its operational and risk management processes.
OCI&#8217;s ammonia production, though smaller than its methanol output, offers Methanex a low-risk entry into a complementary commodity.
The transaction, which has been approved by both companies&#8217; boards, is expected to close in the first half of 2025.
It remains subject to regulatory approvals and other closing conditions, including TSX approval for the issuance of Methanex shares to OCI.
After the transaction, Methanex will have approximately 77 million shares outstanding, with OCI owning about 13%.
Methanex plans to fund the cash portion through a mix of cash on hand and new debt, supported by a fully committed financing package from the Royal Bank of Canada.
Dean Richardson, Senior Vice President, Finance &amp; Chief Financial Officer of Methanex, commented, &#8220;We expect the acquisition to add incremental annual Adjusted EBITDA of $275 million to our expected run-rate Adjusted EBITDA of $850 million at a $350/MT realized methanol price.&#8221;
&#8220;We remain firmly committed to maintaining financial flexibility and have in place a robust financing plan that will support de-levering to our target range of 2.5 to 3.0 times debt/Adjusted EBITDA within approximately 18 months from closing, assuming an average realized price of $350/MT. The plan includes the repayment of our $300 million bond as scheduled in December 2024.&#8221;
As of June-end, the company maintained a strong liquidity position <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/g40052912/geismar-3-g3-produces-first-methanol-and-methanex-reports-higher-second-quarter-2024-earnings" rel="noreferrer noopener">with a cash balance of $426 million</a>.
Investors can gain exposure to the stock via American Beacon Select Funds American Beacon GLG Natural Resources ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGNR#NYSE">MGNR</a>).
Price Action: MEOH shares closed lower by 5.60% at $42.45 on Friday.
Image via Shutterstock
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/40767621" target="_blank" rel="noreferrer noopener">Elon Musk Refutes Reports Of xAI Negotiating Revenue Share Deal With Tesla: &#8216;There Is No Need To License Anything&#8217;</a></li>
</ul>
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

Mid Cap

MEOH

MGNR

Methanex To Buy OCI's International Methanol Business For $2.05B: Details

Aurora Cannabis Inc. ("Aurora") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ACB#TSX">ACB</a>), a leading Canadian-based global medical cannabis company, and Vectura Fertin Pharma, Inc., an innovator in wellness and healthcare, are pleased to announce the launch of the newly developed Luo CBD lozenge.
&nbsp;
The high-quality CBD lozenge was developed by Vectura Fertin Pharma and adheres to stringent safety, quality and regulatory standards to address unmet medical and health needs. It is the first of Vectura Fertin Pharma's medical cannabis products to launch in Canada. The CBD lozenge is being manufactured, packaged and labelled by Cogent, a Vectura Fertin Pharma subsidiary, for sale and will be distributed by Aurora through its leading direct-to-patient e-commerce platform. The CBD lozenge, which has a novel dissolvable format and is easy to dose, is now available for patients on Aurora's Canadian medical cannabis patient platform as authorised by healthcare professionals.

TSX:ACB

Aurora Cannabis Launches New CBD Lozenge in Canada, Developed with Vectura Fertin Pharma

Shares of artificial intelligence-powered data analytics company Palantir Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) climbed sharply <a href="https://www.benzinga.com/premarket">in premarket trading </a>on Monday.
The gains can be traced back to a late-Friday announcement from S&amp;P Dow Jones Indices that Palantir would be added to the S&amp;P 500 Index, ahead of the start of trading on Sept. 23. Despite widespread anticipation, the S&amp;P had snubbed Palantir in its two previous quarterly rebalancing.
The S&amp;P 500 Index is considered the best single gauge of large-cap U.S. equities and includes 500 leading companies, covering approximately 80% of available market capitalization.&nbsp;
The eligibility criteria for S&amp;P 500 Index inclusion are a market capitalization of $15.8 billion or more, an annual dollar value traded to float-adjusted market capitalization greater than 0.75, a listing in either NYSE or NASDAQ and a primary listing in the U.S. There is a trading-volume criterion as well.
Index inclusion is typically positive for stocks, as funds holding portfolios mirroring the index will buy them to maintain the respective weightings of the component stocks. The stock will also benefit from increased volume and liquidity due to purchases by index funds and ETFs.
Following the development, Wedbush analyst Daniel Ives said, &#8220;The profitability profile of this story has significantly been bolstered with <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40766713/palantirs-s-p-500-inclusion-another-validation-moment-as-it-embarks-on-new-era-of-e">this another validation moment for the Palantir story.&#8221;</a>
In premarket trading, Palantir shares 6.73% to $32.37, according to<a href="https://benzinga.grsm.io/register174"> Benzinga Pro data.</a> Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) and Erie Indemnity Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ERIE#NASDAQ">ERIE</a>), which also made it to the index, rose 6.02% and 2.89%, respectively, in the premarket.
See Also: <a href="https://www.benzinga.com/money/best-artificial-intelligence-stocks">Best AI Stocks</a>
Photo by Spyro the Dragon on Shutterstock

Markets

Movers

Tech

Trading Ideas

DELL

ERIE

PLTR

Palantir Stock Soars In Monday Premarket: What's Driving The Surge?

RILY

B Riley Board Has Established A Special Committee To Evaluate The Take Private Proposal

Earnings

Mobilicom H1 EPS $(0.11) Inline YoY, Sales $1.80M Up From $0.54M YoY

TERN

Terns Pharmaceuticals Announced Topline Data From Its Phase 1 Trial Of TERN-601 Dosed Once-daily In Healthy Adults With Obesity Or Overweight, Showed A Statistically Significant Mean Weight Loss Up To 5.5% Over 28 Days

mmunovant also disclosed data from several proprietary market research studies that showed a consistent unmet need among ATD treated patients who are intolerant to, uncontrolled on or relapsed after ATDs.
Finally, Immunovant also announced alignment with the FDA&nbsp;and Investigational New Drug Application&nbsp;clearance with initiation of a pivotal trial of IMVT-1402 in GD expected by December 31, 2024.
<ul>
<li>High dose batoclimab achieved&nbsp;56%&nbsp;ATD-free response rate in patients uncontrolled on ATDs at week 12</li>
<li>Strong correlation observed between degree of IgG lowering and clinical outcomes yields potential best-in-class and first-in-class opportunity for IMVT-1402 in Graves&#39; Disease (GD)</li>
<li>IND cleared with initiation of IMVT-1402 pivotal trial in GD expected by calendar year end</li>
</ul>

IMVT

ROIV

Roivant Says Immunovant Reported Results From Phase 2a Trial Of Batoclimab In Graves' Disease; Says High Dose Batoclimab Achieved 76% Response Rate In Patients Uncontrolled On Antithyroid Drugs At Week 12

JMP Securities analyst Aaron Hecht maintains Independence Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IRT#NYSE">IRT</a>) with a Market Outperform and raises the price target from $20 to $22.

JMP Securities Maintains Market Outperform on Independence Realty Trust, Raises Price Target to $22

B Riley  Negotiating Sale Of Majority Stake In Great American Group At $380M Enterprise Value; Financing Of Brands Portfolio For $236M;
Anticipates Receiving ~$410M Of Gross Cash Proceeds From Two Transactions

Evaxion Biotech A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVAX#NASDAQ">EVAX</a>) ("Evaxion"), a clinical-stage TechBio company specializing in developing AI-Immunology&#x2122; powered vaccines, announces new pre-clinical data demonstrating the ability of its novel EVX-B2 mRNA Gonorrhea vaccine candidate in eliminating gonorrhea bacteria by triggering a targeted immune response.
This new data, which will be presented today at the 18th Vaccine Congress taking place in Lisbon, Portugal, provides strong Proof-of-Concept (PoC) for the mRNA-based version of EVX-B2 in a pre-clinical setting.
EVX-B2 was initially designed as a protein-based prophylactic vaccine candidate for which pre-clinical PoC has already been obtained. The novel pre-clinical data for the mRNA-version of the vaccine substantiates that AI-Immunology&#x2122; identified vaccine antigens are delivery modality agnostic and can be applied across different vaccine modalities. The new data has been generated in collaboration with Afrigen Biologics.

Gain an Edge Using Pro's Market Moving News Breaks — 50% OFF

Gain an Edge Using Pro's Market Moving News Breaks — 50% OFF

Comments

Nitori Holdings

Nitori Holdings (NCLTY) Forecast

Nitori Holdings (OTC:NCLTY) Stock, Quote.Headers.trade-ideas